Aterian (ATER) Q4 2025 earnings summary

Executive summary

• Net revenue declined 30.4% year-over-year to $69.0 million, driven by tariff-related price increases and softer consumer demand.

• Operating loss widened to $18.0 million from $11.8 million in 2024, with a net loss of $19.0 million.

• The company initiated a process to explore strategic alternatives, including a potential sale or merger.

• Substantial doubt exists about the company's ability to continue as a going concern due to recurring losses and negative cash flows.

Financial highlights

• Gross profit margin decreased to 56.8% from 62.1% year-over-year, impacted by tariffs and product mix.

• Adjusted EBITDA was negative $8.0 million, compared to negative $2.1 million in 2024.

• Cash used in operating activities was $10.9 million, with unrestricted cash of $4.9 million at year-end.

• Stock-based compensation expense fell 71% to $2.2 million.

• A non-cash impairment charge of $3.8 million was recorded for certain brand intangible assets.

Outlook and guidance

• Management expects continued pressure from tariffs, inflation, and reduced consumer spending.

• Ongoing cost reduction initiatives and product rationalization are expected to improve profitability over time.

• The company is evaluating further structural and operational measures to mitigate tariff exposure.